Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) NATCO Pharma informs about transcript of conference call
Date: 04-06-2022NATCO Pharma has informed that it enclosed a copy of the transcript of the Company's earnings conference call for Q4 FY22 held on May 31, 2022. This transcript is also uploaded on its website www.natcopharma.co.in.
The above information is a part of company’s filings submitted to BSE.